Figure 4From: Management of patients with uncontrolled arterial hypertension – the role of electronic compliance monitoring, 24-h ambulatory blood pressure monitoring and Candesartan/HCTObserved Daily probability of intake after week 4 visit. The compliance after week 4 is not different in the three groups and stayed constant over time.Back to article page